Literature DB >> 28159349

Elimination of hepatitis C in Spain: Adaptation of a mathematical model based on the public health strategic plan for addressing hepatitis C in the National Health System.

María Buti1, Jose Luis Calleja2, Javier García-Samaniego3, Miguel Ángel Serra4, Javier Crespo5, Manuel Romero6, Miguel Ángel Simón7, Juan Turnes8, Antonio Javier Blasco9, Pablo Lázaro9, Sarah Robbins10, Homie Razavi10.   

Abstract

Mesh：

Year:  2017        PMID： 28159349     DOI： 10.1016/j.medcli.2016.12.018

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN： 0025-7753            Impact factor:   1.725


× No keyword cloud information.
  6 in total

Review 1.  Population Health and Cost-Effectiveness Implications of a "Treat All" Recommendation for HCV: A Review of the Model-Based Evidence.

Authors:  Lauren E Cipriano; Jeremy D Goldhaber-Fiebert
Journal:  MDM Policy Pract       Date:  2018-05-24

2.  Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay.

Authors:  V Saludes; A Antuori; B Reinhardt; I Viciana; E Clavijo; L Schreiber; M Tenenbaum; F Rodriguez-Frias; J Quer; L Matas; E Martró
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

3.  Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence.

Authors:  F Ledesma; M Buti; R Domínguez-Hernández; M A Casado; R Esteban
Journal:  Rev Esp Quimioter       Date:  2020-06-08       Impact factor: 1.553

4.  Healthcare value of implementing hepatitis C screening in the adult general population in Spain.

Authors:  María Buti; Raquel Domínguez-Hernández; Miguel Ángel Casado; Eliazar Sabater; Rafael Esteban
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

5.  Is it possible to eliminate hepatitis C from the prisons of Catalonia, Spain, in 2021?

Authors:  A Marco; R A Guerrero; E Turu; C Gallego; N Teixidó; A Sastre; J A Caylà
Journal:  Rev Esp Sanid Penit       Date:  2019-06-01

6.  Integrating hepatitis C care for at-risk groups (HepLink): baseline data from a multicentre feasibility study in primary and community care.

Authors:  Eithne Nic An Riogh; Davina Swan; Geoff McCombe; Eileen O'Connor; Gordana Avramovic; Juan Macías; Cristiana Oprea; Alistair Story; Julian Surey; Peter Vickerman; Zoe Ward; John S Lambert; Willard Tinago; Irina Ianache; Maria Iglesias; Walter Cullen
Journal:  J Antimicrob Chemother       Date:  2019-11-01       Impact factor: 5.790
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.